WO2000055346A3 - Methods and materials for the rapid and high volume production of a gene knock-out library in an organism - Google Patents

Methods and materials for the rapid and high volume production of a gene knock-out library in an organism

Info

Publication number
WO2000055346A3
WO2000055346A3 PCT/US2000/007317 US0007317W WO0055346A3 WO 2000055346 A3 WO2000055346 A3 WO 2000055346A3 US 0007317 W US0007317 W US 0007317W WO 0055346 A3 WO0055346 A3 WO 0055346A3
Authority
WO
WIPO (PCT)
Prior art keywords
vector
organism
large insert
rapid
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/007317
Other languages
French (fr)
Other versions
WO2000055346A2 (en
Inventor
John E Hamer
Lisbeth Hamer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Icoria Inc
Original Assignee
Paradigm Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paradigm Genetics Inc filed Critical Paradigm Genetics Inc
Priority to JP2000605763A priority Critical patent/JP2003502015A/en
Priority to EP00918144A priority patent/EP1161551A2/en
Priority to AU39007/00A priority patent/AU3900700A/en
Publication of WO2000055346A2 publication Critical patent/WO2000055346A2/en
Publication of WO2000055346A3 publication Critical patent/WO2000055346A3/en
Priority to US09/826,630 priority patent/US6562624B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to a method for facilitating site directed homologous recombination in an organism to produce mutants comprising: 1) constructing a large insert vector library comprising one or more large insert vectors; 2) constructing a second vector comprising a transposable element; 3) incubating the product of step 1) with the product of step 2) in the presence of a transposase specific for the inverted repeat sequences on the plasmid vector; 4) amplifying the disrupted large insert vector resulting from step 3); 5) introducing the disrupted large insert vector produced by step 4) into a target host cell; and 6) selecting for successful homologous recombination produced by step 5) with the second selectable marker.
PCT/US2000/007317 1999-03-17 2000-03-16 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism Ceased WO2000055346A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2000605763A JP2003502015A (en) 1999-03-17 2000-03-16 Methods and materials for rapid and mass production of gene knockout libraries in organisms
EP00918144A EP1161551A2 (en) 1999-03-17 2000-03-16 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism
AU39007/00A AU3900700A (en) 1999-03-17 2000-03-16 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism
US09/826,630 US6562624B2 (en) 1999-03-17 2001-04-05 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27062099A 1999-03-17 1999-03-17
US09/270,620 1999-03-17

Publications (2)

Publication Number Publication Date
WO2000055346A2 WO2000055346A2 (en) 2000-09-21
WO2000055346A3 true WO2000055346A3 (en) 2001-02-15

Family

ID=23032091

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/007317 Ceased WO2000055346A2 (en) 1999-03-17 2000-03-16 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism

Country Status (4)

Country Link
EP (1) EP1161551A2 (en)
JP (1) JP2003502015A (en)
AU (1) AU3900700A (en)
WO (1) WO2000055346A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005255B2 (en) 2000-04-14 2006-02-28 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
CN108611361A (en) * 2018-05-10 2018-10-02 浙江大学 A kind of genetic screening method of streptomycete biological synthesis gene cluster negative regulatory factor

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033781B1 (en) 1999-09-29 2006-04-25 Diversa Corporation Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
US6673567B2 (en) * 2000-03-23 2004-01-06 E. I. Du Pont De Nemours And Company Method of determination of gene function
WO2001096551A2 (en) * 2000-06-14 2001-12-20 Diversa Corporation Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating
US20020094536A1 (en) * 2000-12-28 2002-07-18 Cell Therapeutics, Inc. Methods for making polynucleotide libraries, polynucleotide arrays, and cell libraries for high-throughput genomics analysis
US7138267B1 (en) 2001-04-04 2006-11-21 Epicentre Technologies Corporation Methods and compositions for amplifying DNA clone copy number
EP1499739B1 (en) 2002-04-22 2016-03-30 Novozymes, Inc. Methods for increasing homologous recombination of a nucleic acid sequence
AU2003231228A1 (en) * 2002-04-22 2003-11-03 Novozymes Biotech, Inc. Methods for preparing variants of a dna sequence in filamentous fungi
US8849577B2 (en) 2006-09-15 2014-09-30 Metabolon, Inc. Methods of identifying biochemical pathways
CN108728477B (en) * 2017-04-24 2022-02-22 华东理工大学 Efficient transposition mutation system and construction method

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102797A (en) * 1989-05-26 1992-04-07 Dna Plant Technology Corporation Introduction of heterologous genes into bacteria using transposon flanked expression cassette and a binary vector system
WO1997029202A1 (en) * 1996-02-09 1997-08-14 Het Nederlands Kanker Instituut Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
WO1998010077A1 (en) * 1996-09-09 1998-03-12 Wisconsin Alumni Research Foundation System for in vitro transposition using modified tn5 transposase
WO1998056903A1 (en) * 1997-06-13 1998-12-17 President And Fellows Of Harvard College Methods and uses for transposon-based gene targeting
WO1999007871A1 (en) * 1997-08-12 1999-02-18 Het Nederlands Kanker Instituut Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
WO1999009817A1 (en) * 1997-08-22 1999-03-04 Biotechnology And Biological Sciences Research Council Use of mariner transposan in the production of transgenic animals

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102797A (en) * 1989-05-26 1992-04-07 Dna Plant Technology Corporation Introduction of heterologous genes into bacteria using transposon flanked expression cassette and a binary vector system
WO1997029202A1 (en) * 1996-02-09 1997-08-14 Het Nederlands Kanker Instituut Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
WO1998010077A1 (en) * 1996-09-09 1998-03-12 Wisconsin Alumni Research Foundation System for in vitro transposition using modified tn5 transposase
WO1998056903A1 (en) * 1997-06-13 1998-12-17 President And Fellows Of Harvard College Methods and uses for transposon-based gene targeting
WO1999007871A1 (en) * 1997-08-12 1999-02-18 Het Nederlands Kanker Instituut Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
WO1999009817A1 (en) * 1997-08-22 1999-03-04 Biotechnology And Biological Sciences Research Council Use of mariner transposan in the production of transgenic animals

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ADACHI KIICHI AND J.E. HAMER: "Divergent cAMP signaling pathways regulate growth and pathogenesis in the rice blast fungus Magnaporthe grisea.", PLANT CELL, vol. 10, no. 8, August 1998 (1998-08-01), pages 1361 - 1373, XP002145186, ISSN: 1040-4651 *
LAMPE DAVID J ET AL: "A purified mariner transposase is sufficient to mediate transposition in vitro.", EMBO (EUROPEAN MOLECULAR BIOLOGY ORGANIZATION) JOURNAL, vol. 15, no. 19, 1996, pages 5470 - 5479, XP002145182, ISSN: 0261-4189 *
LAMPE DAVID J ET AL: "Factors affecting transposition of the Himar1 mariner transposon in vitro.", GENETICS, vol. 149, no. 1, May 1998 (1998-05-01), pages 179 - 187, XP002145183, ISSN: 0016-6731 *
NISHIMURA MARIE ET AL: "Construction of a BAC library of the rice blast fungus Magnaporthe grisea and finding specific genome regions in which its transposons tend to cluster.", BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, vol. 62, no. 8, August 1998 (1998-08-01), pages 1515 - 1521, XP002145184, ISSN: 0916-8451 *
RUBIN ERIC J ET AL: "In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 96, no. 4, 16 February 1999 (1999-02-16), Feb. 16, 1999, pages 1645 - 1650, XP002145185, ISSN: 0027-8424 *
S.E. DEVINE ET AL.: "A transposon-based strategy for sequencing repetitive DNA in eucaryotic genomes", GENOME RESEARCH, vol. 7, 1997, CSH LABORATORY PRESS, pages 551 - 563, XP002145187 *
WESTPHAL CHRISTOPH HEINER ET AL: "Transposon-generated 'knock-out' and 'knock-in' gene-targeting constructs for use in mice.", CURRENT BIOLOGY, vol. 7, no. 7, 1997, pages 530 - 533, XP000938425, ISSN: 0960-9822 *
ZHANG L ET AL: "THE HIMAR1 MARINER TRANSPOSASE CLONED IN A RECOMBINANT ADENOVIRUS VECTOR IS FUNCTIONAL IN MAMMALIAN CELLS", NUCLEIC ACIDS RESEARCH,GB,OXFORD UNIVERSITY PRESS, SURREY, vol. 26, no. 16, August 1998 (1998-08-01), pages 3687 - 3693, XP000700201, ISSN: 0305-1048 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005255B2 (en) 2000-04-14 2006-02-28 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7550258B2 (en) 2000-04-14 2009-06-23 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7550260B2 (en) 2000-04-14 2009-06-23 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7553616B2 (en) 2000-04-14 2009-06-30 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7635556B2 (en) 2000-04-14 2009-12-22 Cornell Research Foundation, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US7947453B2 (en) 2000-04-14 2011-05-24 Metabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
CN108611361A (en) * 2018-05-10 2018-10-02 浙江大学 A kind of genetic screening method of streptomycete biological synthesis gene cluster negative regulatory factor

Also Published As

Publication number Publication date
EP1161551A2 (en) 2001-12-12
JP2003502015A (en) 2003-01-21
WO2000055346A2 (en) 2000-09-21
AU3900700A (en) 2000-10-04

Similar Documents

Publication Publication Date Title
Weninger et al. Expanding the CRISPR/Cas9 toolkit for Pichia pastoris with efficient donor integration and alternative resistance markers
Wang et al. Efficient genome editing in Fusarium oxysporum based on CRISPR/Cas9 ribonucleoprotein complexes
Nielsen et al. Efficient PCR-based gene targeting with a recyclable marker for Aspergillus nidulans
Brachmann et al. A reverse genetic approach for generating gene replacement mutants in Ustilago maydis
Zhang et al. Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
WO1999015682A3 (en) Gene silencing materials and methods
PL361927A1 (en) Methods of modifying eukaryotic cells
CA2208515A1 (en) Method for generating proteolytic enzymes specific against a selected peptide sequence
EP2264163A3 (en) Methods of modifying eukaryotic cells
ATE414782T1 (en) METHOD FOR PRODUCING POLYPEPTIDES IN MUTATED ASPERGILLUS CELLS
SG173213A1 (en) Identification of genes
Liu et al. Combined genome editing and transcriptional repression for metabolic pathway engineering in Corynebacterium glutamicum using a catalytically active Cas12a
MY106504A (en) Library screening method.
TW200504213A (en) Method of preparing amino acids by fermentation with the constructed amino acid producing bacteria
Solis-Escalante et al. Efficient simultaneous excision of multiple selectable marker cassettes using I-SceI-induced double-strand DNA breaks in Saccharomyces cerevisiae
WO1999060137A3 (en) Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells
Johansson et al. Overproduction of pentose phosphate pathway enzymes using a new CRE–loxP expression vector for repeated genomic integration in Saccharomyces cerevisiae
US7115413B2 (en) Meiotic recombination in vivo of partially homologous DNA sequences
Abdulrachman et al. Efficient multiplex CRISPR/Cpf1 (Cas12a) genome editing system in Aspergillus aculeatus TBRC 277
Chen et al. Development of a CRISPR/Cpf1 system for multiplex gene editing in Aspergillus oryzae
WO2003035834A3 (en) Compositions and methods for making mutations in cell lines and animals
US6703200B1 (en) Methods and materials for the rapid and high volume production of a gene knock-out library in an organism
WO2001071040A3 (en) Method for determination of gene function
Foureau et al. Characterization of an autonomously replicating sequence in Candida guilliermondii
Griesbeck CRISPR/Cas9-based directed evolution in mammalian cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2000918144

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 605763

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000918144

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000918144

Country of ref document: EP